Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Modern Diagnostic & Research Centre Days Payable?
Modern Diagnostic & Research CentreBOM:544673 15 Days Payable is 166.12 as of Mar. 2026, which is 5% above its 10-year median of 157.88. GuruFocus rates BOM:544673 with a GF Score™ of 15/100. The stock has 7 warning signs investors should review. Among 190 Medical Diagnostics & Research companies, Modern Diagnostic & Research Centre ranks better than 87.37% on this metric.
BOM:544673'
s Days Payable Range Over the Past 10 Years
Min: 143.68 Med: 157.88 Max: 332.24
Current: 332.24
During the past 4 years, Modern Diagnostic & Research Centre's highest Days Payable was 332.24. The lowest was 143.68. And the median was 157.88.
BOM:544673's Days Payable is ranked better than 87.37% of 190
companies
in the Medical Diagnostics & Research industry
Industry Median: 67.075
vs BOM:544673: 332.24
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Modern Diagnostic & Research Centre Days Payable Chart
Modern Diagnostic & Research Centre Annual Data
Trend
Mar23
Mar24
Mar25
Mar26
Days Payable
143.68
152.60
163.15
167.90
Modern Diagnostic & Research Centre Semi-Annual Data
Mar23
Mar24
Mar25
Mar26
Days Payable
0.00
0.00
0.00
166.12
BOM:544673 vs TMO, DHR, IDXX: Days Payable Comparison
For the Diagnostics & Research subindustry, Modern Diagnostic & Research Centre's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Modern Diagnostic & Research Centre Days Payable vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Modern Diagnostic & Research Centre's Days Payable distribution charts can be found below:
* The bar in red indicates where Modern Diagnostic & Research Centre's Days Payable falls into.
Modern Diagnostic & Research Centre Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Modern Diagnostic & Research Centre (BOM:544673) has a Days Payable of 166.12 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Modern Diagnostic & Research Centre and its competitors. This is near median its historical median of 157.88. Over the past decade, Modern Diagnostic & Research Centre's Days Payable has ranged from 143.68 to 332.24. According to the industry distribution chart, Modern Diagnostic & Research Centre ranks #24 out of 190 companies in the Medical Diagnostics & Research industry, placing it in the top 12.6%.
Is Modern Diagnostic & Research Centre's Days Payable too high?
Modern Diagnostic & Research Centre's current Days Payable of 166.12 is near median its 10-year median of 157.88. Over the past 10 years, this metric has ranged from a low of 143.68 to a high of 332.24. The Medical Diagnostics & Research industry median Days Payable is 67.08. Modern Diagnostic & Research Centre's value of 166.12 is 147.7% above this industry median. Based on the distribution chart, Modern Diagnostic & Research Centre ranks #24 out of 190 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Modern Diagnostic & Research Centre has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Modern Diagnostic & Research Centre's Days Payable compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Modern Diagnostic & Research Centre ranks #24 out of 190 companies for Days Payable. This places Modern Diagnostic & Research Centre in the top 13% of its industry — outperforming the majority of peers. The industry median Days Payable is 67.08. Modern Diagnostic & Research Centre's value of 166.12 is 147.7% above this benchmark. Historically, Modern Diagnostic & Research Centre's own Days Payable has ranged from 143.68 to 332.24 over the past decade. While the company's 10-year median is 157.88 vs. the industry median of 67.08, Modern Diagnostic & Research Centre has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Diagnostics & Research company?
The median Days Payable among Medical Diagnostics & Research companies is 67.08, based on 190 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Modern Diagnostic & Research Centre's current Days Payable of 166.12 is 147.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Modern Diagnostic & Research Centre and its competitors. For the Medical Diagnostics & Research industry, the median Days Payable is 67.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Modern Diagnostic & Research Centre's current Days Payable is 166.12, which is near median its own 10-year median of 157.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Modern Diagnostic & Research Centre stock overvalued right now?
Modern Diagnostic & Research Centre (BOM:544673) has a current Days Payable of 166.12. The current Days Payable is 166.12, which is near median its 10-year median of 157.88 and 147.7% above the Medical Diagnostics & Research industry median of 67.08. Modern Diagnostic & Research Centre's overall GF Score™ is 15/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Modern Diagnostic & Research Centre (BOM:544673), the current Days Payable is 166.12 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Modern Diagnostic & Research Centre Ltd is a services provider in diagnostic and related healthcare tests services in India. It offers a one-stop solution for pathology and radiology testing services such as imaging (including radiology), pathology/clinical laboratory. Through Its integrated, nationwide network, it offers a complete range of diagnostic facilities in radiology and pathology. The company provides healthcare tests and services for use in core testing, patients' diagnosis and prevention, monitoring of disease and other health conditions. Its customers include individual patients, hospitals and other healthcare providers and corporate customers.
15GF Score
Get the complete analysis for BOM:544673
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544673 has been successfully added to your 
